Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 2/20 | 0.41 |
| ▸ | PRKCG | P05129 | 2/20 | 0.41 |
| ▸ | PRKCB | P05771 | 2/20 | 0.41 |
| ▸ | PRKCA | P17252 | 2/20 | 0.41 |
| ▸ | PRKCH | P24723 | 2/20 | 0.41 |
| ▸ | PRKCI | P41743 | 2/20 | 0.41 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.41 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.41 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.41 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.41 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.39 |
| ▸ | LPAR6 | P43657 | 5/20 | 0.39 |
| ▸ | LPAR4 | Q99677 | 5/20 | 0.39 |
| ▸ | LPAR5 | Q9H1C0 | 5/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | AKT1 | P31749 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10028008 | 1.00 | PRKD3 (0.41) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL13225891 | 1.00 | PRKD3 (0.41) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL51157 | 0.90 | — | — | |
| SCHEMBL13166788 | 0.89 | CYP2C9 (0.44) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL19067466 | 0.89 | CYP2C9 (0.44) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL19546092 | 0.89 | PRKD3 (0.36) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL19749216 | 0.87 | LPAR1 (0.42) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL12355616 | 0.87 | PRKD3 (0.39) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL14730146 | 0.87 | PRKD3 (0.35) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL26709585 | 0.87 | LPAR1 (0.42) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11786444-B2 | Dental polyfunctional monomers and dental hydroxyl group-containing monomers | MITSUI CHEMICALS, INC. (JP) | 2023-10-17 | — | — | US | disclosed |
| US-20230257517-A1 | PROCESS FOR PREPARING CARBOXYLIC ACID ESTER-CROSS-LINKED POLYGLYCEROL ESTERS OF 3-HYDROXYBUTYRIC ACID | KETOLIPIX THERAPEUTICS GMBH (DE) | 2023-08-17 | — | — | US | disclosed |
| US-20230257517-A1 | PROCESS FOR PREPARING CARBOXYLIC ACID ESTER-CROSS-LINKED POLYGLYCEROL ESTERS OF 3-HYDROXYBUTYRIC ACID | KETOLIPIX THERAPEUTICS GMBH (DE) | 2023-08-17 | — | — | US | disclosed |
| EP-4184649-A1 | LITHIUM ION BATTERY, BATTERY MODULE COMPRISING SAME, BATTERY PACK, AND ELECTRICAL APPARATUS | Contemporary Amperex Technology Co., Limited (CN) | 2023-05-24 | — | — | EP | disclosed |
| US-11518728-B2 | Multi-arm single molecular weight polyethylene glycol, active derivative thereof, and preparation and application thereof | JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) | 2022-12-06 | — | — | US | disclosed |
| WO-2022012768-A1 | PROCESS FOR PREPARING POLYCARBOXYLIC ACID ESTER-CROSS-LINKED POLYGLYCEROL ESTERS OF 3-HYDROXYBUTYRIC ACID | IOI OLEO GMBH (DE) | 2022-01-20 | — | — | WO | disclosed |
| US-11202796-B2 | Branched polyethylene glycol epoxy derivative crosslinked sodium hyaluronate gel, preparation and application thereof | JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) | 2021-12-21 | — | — | US | disclosed |
| US-11155672-B2 | Surface treatment agent | DAIKIN INDUSTRIES, LTD. (JP) | 2021-10-26 | — | — | US | disclosed |
| US-10696788-B2 | Surface treatment agent | DAIKIN INDUSTRIES, LTD. (JP) | 2020-06-30 | — | — | US | disclosed |
| US-20200131109-A1 | MULTI-ARM SINGLE MOLECULAR WEIGHT POLYETHYLENE GLYCOL, ACTIVE DERIVATIVE THEREOF, AND PREPARATION AND APPLICATION THEREOF | JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) | 2020-04-30 | — | — | US | disclosed |
| US-20110105413-A1 | POLYMERIC SYSTEMS CONTAINING INTRACELLULAR RELEASABLE DISULFIDE LINKER FOR THE DELIVERY OF OLIGONUCLEOTIDES | ENZON PHARMACEUTICALS, INC. (US) | 2011-05-05 | — | — | US | disclosed |
| US-20100203066-A1 | POLYMERIC LINKERS CONTAINING PYRIDYL DISULFIDE MOIETIES | ENZON PHARMACEUTICALS, INC. (US) | 2010-08-12 | — | — | US | disclosed |
| US-20100203066-A1 | POLYMERIC LINKERS CONTAINING PYRIDYL DISULFIDE MOIETIES | ENZON PHARMACEUTICALS, INC. (US) | 2010-08-12 | — | — | US | disclosed |
| US-20100006998-A1 | LIQUID RESIN COMPOSITION, SEMICONDUCTOR WAFER HAVING ADHESIVE LAYER, SEMICONDUCTOR ELEMENT HAVING ADHESIVE LAYER, SEMICONDUCTOR PACKAGE, PROCESS FOR MANUFACTURING SEMICONDUCTOR ELEMENT AND PROCESS FOR MANUFACTURING SEMICONDUCTOR PACKAGE | SUMITOMO BAKELITE CO., LTD. (JP) | 2010-01-14 | — | — | US | disclosed |
| US-20090203706-A1 | LYSINE-BASED POLYMERIC LINKERS | ENZON PHARMACEUTICALS, INC. (US) | 2009-08-13 | — | — | US | disclosed |
| US-20090047270-A1 | ENZYMATIC ANTICANCER THERAPY | ENZON PHARMACEUTICALS, INC. (US) | 2009-02-19 | — | — | US | disclosed |
| US-20090016985-A1 | POLYMERIC DRUG DELIVERY SYSTEM CONTAINING A MULTI-SUBSTITUTED AROMATIC MOIETY | ENZON PHARMACEUTICALS, INC. (US) | 2009-01-15 | — | — | US | disclosed |
| US-7427678-B2 | Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method | SIGMA-ALDRICH CO. (US) | 2008-09-23 | — | — | US | disclosed |
| US-20070190001-A1 | Cosmetic composition comprising an ester of polyol(s) and of fatty diacid dimer and a polyamide | L'OREAL (FR) | 2007-08-16 | — | — | US | disclosed |
| US-20070134182-A1 | Cosmetic composition comprising an ester of dimerdilinoleic acid and of polyol(s) and a silicone surfactant | L'OREAL (FR) | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10696788-B2 | Surface treatment agent | MSR1, ITGA2, ITGA1 | PRKD3 3322/4885PRKCG 1912/4885PRKCB 1293/4885 |
| US-20070134182-A1 | Cosmetic composition comprising an ester of dimerdilinoleic acid and of polyol(s) and a silicone surfactant | DEGS1, DAGLA, CUTA | PRKD3 400/4885PRKCG 301/4885PRKCB 936/4885 |
| US-20090047270-A1 | ENZYMATIC ANTICANCER THERAPY | RNASE1, ADA, DCTD | PRKD3 2630/4885PRKCG 2192/4885PRKCB 1875/4885 |
| US-11786444-B2 | Dental polyfunctional monomers and dental hydroxyl group-containing monomers | PAM, CAD, FHIT | PRKD3 1151/4885PRKCG 2386/4885PRKCB 3199/4885 |
| US-11155672-B2 | Surface treatment agent | MSR1, ITGA2, ITGA1 | PRKD3 3322/4885PRKCG 1912/4885PRKCB 1293/4885 |
| US-20090016985-A1 | POLYMERIC DRUG DELIVERY SYSTEM CONTAINING A MULTI-SUBSTITUTED AROMATIC MOIETY | ABCB1, PAICS, ABCG2 | PRKD3 4671/4885PRKCG 4829/4885PRKCB 4834/4885 |
| US-20200131109-A1 | MULTI-ARM SINGLE MOLECULAR WEIGHT POLYETHYLENE GLYCOL, ACTIVE DERIVATIVE THEREOF, AND PREPARATION AND APPLICATION THEREOF | VEGFA, MYD88, FCGR2A | PRKD3 4009/4885PRKCG 2488/4885PRKCB 3947/4885 |
| US-20100203066-A1 | POLYMERIC LINKERS CONTAINING PYRIDYL DISULFIDE MOIETIES | P4HB, PRDX4, SCLY | PRKD3 3222/4885PRKCG 4544/4885PRKCB 4431/4885 |
| US-11202796-B2 | Branched polyethylene glycol epoxy derivative crosslinked sodium hyaluronate gel, preparation and application thereof | CD44, HPSE, ECPAS | PRKD3 3472/4885PRKCG 3748/4885PRKCB 4442/4885 |
| US-20070190001-A1 | Cosmetic composition comprising an ester of polyol(s) and of fatty diacid dimer and a polyamide | KRT18, FASN, CUTA | PRKD3 378/4885PRKCG 552/4885PRKCB 514/4885 |
| US-20090203706-A1 | LYSINE-BASED POLYMERIC LINKERS | KARS1, JMJD6, PHYKPL | PRKD3 2350/4885PRKCG 2479/4885PRKCB 2055/4885 |
| US-20110105413-A1 | POLYMERIC SYSTEMS CONTAINING INTRACELLULAR RELEASABLE DISULFIDE LINKER FOR THE DELIVERY OF OLIGONUCLEOTIDES | CARS1, DNAJC10, RNASE1 | PRKD3 3636/4885PRKCG 3425/4885PRKCB 3557/4885 |
| US-11518728-B2 | Multi-arm single molecular weight polyethylene glycol, active derivative thereof, and preparation and application thereof | VEGFA, MYD88, FCGR2A | PRKD3 4009/4885PRKCG 2488/4885PRKCB 3947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.